Tweet
<img alt="" height="1" width="1" />
New Cholesterol Drugs Face Doctors Seeking Heart Results
Bloomberg
A new class of cholesterol-lowering medicines from Pfizer Inc. (PFE) and Amgen Inc. (AMGN) may struggle to meet sales projections, as latest treatment guidelines suggest doctors should prescribe only drugs proven to help the heart. Called PCSK9 inhibitors ...
and more »
More...